ERBB2 and breast carcinoma: In addition, it was found that HER2 overexpressing breast cancer cells exhibited heightened resistance to anoikis, and the HER2/GSK3/GLI2 pathway was identified to have a new function in the resistance to anoikis and metastasis (9).